Efficacy of Compound α-ketoacid Tablets on renal function and serum indexes in patients with diabetic nephropathy
YOU Ping-ping KE Yuan-yuan XU Jia-qi DAI Lian▲
Department of Endocrinology,the Third People′s Hospital Affiliated to Fujian University of Traditional Chinese Medicine,Fujian Province, Fuzhou 350108, China
Abstract:Objective To explore the efficacy of Compound α-ketoacid Tablets on renal function and serum indexes in patients with diabetic nephropathy. Methods A total of 130 patients with diabetic nephropathy in the Third People′s Hospital Affiliated to Fujian University of Traditional Chinese Medicine from January 2018 to December 2020 were selected as subjects and divided into the test group and the control group according to random number table method,65 cases in each group. The control group received conventional treatment, and the test group was based on the control group, taking Compound α-ketoacid Tablets. Both groups were given treatment for 3 consecutive months. The changes of renal function index, renal interstitial fibrosis index and oxidative stress response index were compared between the two groups before and after treatment. Results After treatment, serum urea nitrogen (BUN), blood creatinine (Cr), homocysteine (Hcy), vascular endothelial growth factor (VEGF) and malondialdehyde (MDA) levels in the test group were lower than those in the control group, the differences were statistically significant (P<0.05). Serum levels of hepatocyte growth factor (HGF), total antioxidant capacity (T-AOC) and superoxide dismutase (SOD) in the test group after treatment were higher than those in the control group, the differences were statistically significant (P<0.05). After treatment,the glomerular filtration rate (GFR) of the test group was faster than that of the control group, the difference was statistically significant (P<0.05). Conclusion Compound α-ketoacid Tablets can protect the renal function of patients with diabetic nephropathy, inhibit the occurrence of oxidative stress, and improve the indicators of renal interstitial fibrosis,and promote the improvement of the condition.
游平平;柯媛媛;许珈齐;代莲▲. 复方α- 酮酸片治疗对糖尿病肾病患者肾功能及血清指标的影响[J]. 中国当代医药, 2021, 28(34): 116-119.
YOU Ping-ping ;KE Yuan-yuan; XU Jia-qi; DAI Lian▲. Efficacy of Compound α-ketoacid Tablets on renal function and serum indexes in patients with diabetic nephropathy. 中国当代医药, 2021, 28(34): 116-119.